Oxford Instruments reiterates FY guidance
Manufacturing and research company Oxford Instruments Plc reaffirmed its full‑year guidance on Thursday, with adjusted operating profits expected to be in line with market forecasts of £70.2m to £73.0m.
Oxford Instruments reported further progress in its imaging and analysis division, where order intake rose 2.4% on an organic constant currency basis. It also said the division's year‑to‑date book‑to‑bill ratio stands at 1.1, with cost‑reduction measures completed in the first half at its Belfast imaging unit delivering the anticipated benefits in the second half.
The FTSE 250-listed firm said its advanced technologies unit continued to see strong momentum, with year‑to‑date orders up 44.5% OCC, and its order book now offering visibility well into FY27.
At group level, Oxford Instruments said its year‑to‑date book‑to‑bill ratio was 1.2, and stated it was continuing to book and ship new imaging and analysis orders in the fourth quarter, while also focusing on executing its existing order book across both divisions.
Oxford Instruments added that the sale of its NanoScience business had completed on 2 January, generating net cash proceeds of £48.5m after final working‑capital and other adjustments.
Reporting by Iain Gilbert at Sharecast.com
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
